Table 1. Demographic data, clinicopathological features and associated treatments, co‐morbidities, and risk factors for VTE unrelated to cancer in the cohort of patients with lung adenocarcinoma (n = 150).

Abbreviations: BMI, body mass index; CNS, central nervous system; CVC, central venous catheter; CVRF, cardiovascular risk factors; ECOG, Eastern Cooperative Oncology Group; NYHA, New York Heart Association; SD, standard deviation; VTE, venous thromboembolism.